Sarah Alane Andres

Affiliations: 
2002-2009 University of Louisville School of Medicine, Louisville, KY, United States 
Google:
"Sarah Andres"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Andres SA, Bickett KE, Alatoum MA, et al. (2015) Interaction between smoking history and gene expression levels impacts survival of breast cancer patients. Breast Cancer Research and Treatment. 152: 545-56
Metzler MA, Venkatesh SG, Lakshmanan J, et al. (2015) A systems biology approach identifies a regulatory network in parotid acinar cell terminal differentiation. Plos One. 10: e0125153
Andres SA, Wittliff JL. (2014) Co-expression of genes with estrogen receptor-α and progesterone receptor in human breast carcinoma tissue. Hormone Molecular Biology and Clinical Investigation. 12: 377-90
Andres SA, Smolenkova IA, Wittliff JL. (2014) Gender-associated expression of tumor markers and a small gene set in breast carcinoma. Breast (Edinburgh, Scotland). 23: 226-33
Seelan RS, Warner DR, Mukhopadhyay PM, et al. (2013) Epigenetic analysis of laser capture microdissected fetal epithelia. Analytical Biochemistry. 442: 68-74
Andres SA, Brock GN, Wittliff JL. (2013) Interrogating differences in expression of targeted gene sets to predict breast cancer outcome. Bmc Cancer. 13: 326
Andres SA, Wittliff JL, Cheng A. (2013) Protein tyrosine phosphatase 4A2 expression predicts overall and disease-free survival of human breast cancer and is associated with estrogen and progestin receptor status. Hormones & Cancer. 4: 208-21
Andres SA, Bumpus SB, Wittliff JL. (2013) Assessment of phytoestrogen and mycoestrogen recognition by recombinant human estrogen receptor-α using ligand titration arrays. Phytochemical Analysis : Pca. 24: 357-66
Andres SA, Edwards AB, Wittliff JL. (2012) Expression of urokinase-type plasminogen activator (uPA), its receptor (uPAR), and inhibitor (PAI-1) in human breast carcinomas and their clinical relevance. Journal of Clinical Laboratory Analysis. 26: 93-103
Andres SA, Wittliff JL. (2011) Relationships of ESR1 and XBP1 expression in human breast carcinoma and stromal cells isolated by laser capture microdissection compared to intact breast cancer tissue. Endocrine. 40: 212-21
See more...